Skip to main content
AtriCure, Inc. logo

AtriCure, Inc. — Investor Relations & Filings

Ticker · ATRC ISIN · US04963C2098 LEI · 254900B2I6GPHK2EXM59 US Manufacturing
Open in API
Filings indexed 1,189 across all filing types
Latest filing 2018-05-17 Director's Dealing
Country US United States of America
Listing US ATRC

About AtriCure, Inc.

https://www.atricure.com

AtriCure, Inc. is a medical device company focused on developing, manufacturing, and selling technologies for the treatment of atrial fibrillation (Afib), management of the left atrial appendage (LAA), and post-operative pain. The company's product portfolio is primarily utilized by cardiothoracic surgeons and electrophysiologists. Key offerings include surgical ablation systems and the AtriClip® LAA Exclusion System, a widely implanted device for LAA management. Additionally, AtriCure provides cryoablation technology, such as the cryoXT™ Probe, which offers a non-opioid approach to pain management following surgical procedures, including amputation.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2018-05-17 English
FORM 4 SUBMISSION
Director's Dealing
2018-05-17 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a Proxy Statement or related materials filed with the SEC. It specifically states it is "Definitive Additional Materials" related to the Proxy Statement for the 2018 Annual Meeting of Stockholders of AtriCure, Inc. The content focuses on supplemental information regarding Proposal Three, which is the advisory vote on executive compensation (Say on Pay). It discusses executive compensation philosophy, responses to proxy advisory firms, CEO pay, and shareholder voting recommendations. This type of document is not the Proxy Statement itself but additional materials supplementing it. According to the filing definitions, Proxy Solicitation & Information Statement (PSI) includes materials sent to shareholders to provide information and request votes for meetings, which fits this document. The document is over 7,000 characters and contains substantive information related to proxy solicitation, not just an announcement or certification. Therefore, the correct classification is PSI with high confidence.
2018-05-14 English
FORM 4 SUBMISSION
Director's Dealing
2018-05-09 English
10-Q
Interim / Quarterly Report Q1 2018
2018-04-27 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions Item 2.02 "Results of Operations and Financial Condition" and references a press release about financial results for the first quarter ended March 31, 2018. It also mentions a conference call to discuss these results. The document is only 3670 characters long and primarily serves to announce the earnings release and the upcoming call, with the press release attached as an exhibit. There are no detailed financial statements or substantive financial data within the document itself, only a summary and reference to the press release. According to the rules, initial announcements of quarterly financial results (key highlights only) correspond to the Earnings Release (ER) category. The document is not the full earnings report but the initial announcement of quarterly results, which fits the ER classification. Confidence is high given the clear identification of the document as an 8-K announcing quarterly financial results and a press release.
2018-04-26 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.